20Med Therapeutics and CEPI Sign Agreement to Advance ThermoStable Vaccines Technology
CEPI to initially provide up to USD850,000 to 20Med to advance development of 20Med’s bioresponsive polymeric nanoparticle platform for...
top of page
News
Search
- Jun 1, 2021
20Med Therapeutics started research into mRNA vaccines against variants of the SARS-CoV-2 virus
The SARS-CoV-2 pandemic has shown the need to be prepared for an outbreak of an infectious disease. It spurred one of the most promising...
bottom of page